Equities

China Health Management Corp

CNHC:PKL

China Health Management Corp

Actions
  • Price (USD)0.0055
  • Today's Change0.00 / 0.00%
  • Shares traded1.00
  • 1 Year change+10.00%
  • Beta-0.3177
Data delayed at least 15 minutes, as of Nov 04 2024 16:01 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

China Health Management Corp. is a healthcare and management company. The Company is focused on the operation and management of hospitals and the medical industry in China. The Company offers services, including medicine, surgery, gynaecology and obstetrics, paediatrics, emergency medicine, intensive care, stomatology, dermatology, medical cosmetology, preventive medicine, pharmacy, healthcare, psychological consultation therapy, medical consultation, combined Chinese and Western medicine, medical examination, medical imaging, medical functions examination, anaesthesia, pathology, family wards, ophthalmology and otolaryngology, haemodialysis, commissioning hospital management, and hospital management consultation.

  • Revenue in USD (TTM)483.00k
  • Net income in USD-25.60m
  • Incorporated2006
  • Employees56.00
  • Location
    China Health Management Corp3609 Hammerkop Dr. NorthNORTH LAS VEGAS 89084United StatesUSA
  • Phone+1 (415) 841-3570
  • Fax+1 (214) 691-6618
  • Websitehttp://www.chinahealthcorp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
First Choice Healthcare Solutions Inc33.03m-3.07m118.65k53.00--0.006--0.0036-0.1171-0.11711.080.59571.18--2.96---10.67-6.69-14.97-11.63-----9.08-6.00---52.960.0885---2.4449.84-142.38---35.31--
North America Frac Sand Inc0.00-226.72k300.13k3.00---------0.0034-0.00340.00-0.0122------0.00---5,915.30-----------193.66---16.94-----100.00--142.25------
China Health Management Corp.483.00k-25.60m446.30k56.00------0.924-1,378.45-1,378.4525.37-41.350.04251.161.498,625.00-190.82---395.01---2,014.49---4,486.13--0.0203-1,353.25----37.69---363.55------
SPO Global Inc838.00k-540.00k514.46k2.00------0.6139-85.99-85.99131.76-476.561.76-------113.56-305.39----31.1527.31-64.44-384.85---1.45-----17.09-15.1313.03------
Dental Patient Care America Inc476.00k-513.00k554.43k4.00------1.16-0.0215-0.01330.02-0.0305------119,000.00--------23.32---107.77-----3.25----51.11--32.14------
Novo Integrated Sciences Inc13.52m-24.33m687.87k127.00--0.0691--0.0509-1.38-1.380.79550.52250.38048.217.55106,432.80-68.51-29.43-113.88-35.6437.6839.59-180.11-110.250.2227-0.66790.2093--7.117.1759.77---22.73--
QHSLab Inc1.61m-190.50k939.83k4.00------0.5826-0.0199-0.01990.1649-0.03670.909731.8013.83403,272.50-10.74-51.17---197.3159.52---11.81-65.100.1152-0.2641.30--13.34--52.98------
Modern Mobility Aids Inc0.00-1.59m945.54k-----------0.0177-0.01770.00-0.0040.00-------4,668.68---------------------------371.94------
Data as of Nov 04 2024. Currency figures normalised to China Health Management Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.